Furthermore, flow cytometry experiments showed no changes in the expression of either ion channels or activation and exhaustion markers in CD8+ PBTs from HNSCC patients after αPD-1 treatment (Figure 1F; Supplementary Figures S3–S4). The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.